135 related articles for article (PubMed ID: 8329169)
1. Human platelet 5-HT2 receptor binding sites re-evaluated: a criticism of current techniques [corrected].
Steckler T; Rüggeberg-Schmidt K; Müller-Oerlinghausen B
J Neural Transm Gen Sect; 1993; 92(1):11-24. PubMed ID: 8329169
[TBL] [Abstract][Full Text] [Related]
2. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
Arora RC; Meltzer HY
Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 5-HT2A receptor binding in platelets from healthy subjects as studied by [3H]-lysergic acid diethylamide ([3H]-LSD): intra- and interindividual variability.
Spigset O; Mjörndal T
Neuropsychopharmacology; 1997 Apr; 16(4):285-93. PubMed ID: 9094146
[TBL] [Abstract][Full Text] [Related]
5. Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue.
Elliott JM; Kent A
J Neurochem; 1989 Jul; 53(1):191-6. PubMed ID: 2723656
[TBL] [Abstract][Full Text] [Related]
6. Human platelet [125I]R-DOI binding sites. Characterization by in vitro autoradiography.
Himeno A; Saavedra JM
Neuropsychopharmacology; 1990 Feb; 3(1):25-32. PubMed ID: 2306333
[TBL] [Abstract][Full Text] [Related]
7. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
Spigset O; Allard P; Mjörndal T
Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
[TBL] [Abstract][Full Text] [Related]
8. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
[TBL] [Abstract][Full Text] [Related]
9. Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration.
Grahame-Smith DG; Geaney DP; Schachter M; Elliott JM
Experientia; 1988 Feb; 44(2):142-5. PubMed ID: 2894321
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 5-hydroxytryptamine binding sites in the plasma membrane of pig blood platelets.
Hoffmann D; Wesemann W
J Neural Transm; 1985; 61(3-4):193-218. PubMed ID: 3157778
[TBL] [Abstract][Full Text] [Related]
11. Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.
Sadzot B; Baraban JM; Glennon RA; Lyon RA; Leonhardt S; Jan CR; Titeler M
Psychopharmacology (Berl); 1989; 98(4):495-9. PubMed ID: 2505289
[TBL] [Abstract][Full Text] [Related]
12. The 5-hydroxytryptamine receptor of blood platelets.
Pletscher A; Affolter H
J Neural Transm; 1983; 57(4):233-42. PubMed ID: 6655466
[TBL] [Abstract][Full Text] [Related]
13. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder.
Cook EH; Arora RC; Anderson GM; Berry-Kravis EM; Yan SY; Yeoh HC; Sklena PJ; Charak DA; Leventhal BL
Life Sci; 1993; 52(25):2005-15. PubMed ID: 7684805
[TBL] [Abstract][Full Text] [Related]
14. Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets.
McBride PA; Mann JJ; Polley MJ; Wiley AJ; Sweeney JA
Life Sci; 1987 May; 40(18):1799-809. PubMed ID: 3573979
[TBL] [Abstract][Full Text] [Related]
15. Serotonin 5-HT2 receptor binding on blood platelets--a peripheral marker for depression?
Biegon A; Weizman A; Karp L; Ram A; Tiano S; Wolff M
Life Sci; 1987 Nov; 41(22):2485-92. PubMed ID: 3683087
[TBL] [Abstract][Full Text] [Related]
16. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN
Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499
[TBL] [Abstract][Full Text] [Related]
17. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
McKenna DJ; Peroutka SJ
J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
[TBL] [Abstract][Full Text] [Related]
19. Identification of non-serotonergic [3H]ketanserin binding sites on human platelets and their role in serotonin release.
Leysen JE; Gommeren W; Janssen PA
Eur J Pharmacol; 1991 Jan; 206(1):39-45. PubMed ID: 2065715
[TBL] [Abstract][Full Text] [Related]
20. Serotonin receptors in the tissues of adult Ascaris suum.
Chaudhuri J; Donahue MJ
Mol Biochem Parasitol; 1989 Jul; 35(3):191-8. PubMed ID: 2747743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
